CRIS Current Research Information System

SABATTINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.755
AS - Asia 5.457
EU - Europa 4.729
AF - Africa 398
SA - Sud America 334
OC - Oceania 7
Totale 17.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.679
SG - Singapore 1.694
CN - Cina 1.645
GB - Regno Unito 1.216
VN - Vietnam 1.011
SE - Svezia 691
DE - Germania 660
IT - Italia 634
HK - Hong Kong 412
UA - Ucraina 306
IN - India 298
RU - Federazione Russa 265
BR - Brasile 234
FR - Francia 204
IE - Irlanda 190
KR - Corea 134
NL - Olanda 126
CI - Costa d'Avorio 110
ZA - Sudafrica 104
TG - Togo 92
FI - Finlandia 84
JP - Giappone 81
EE - Estonia 67
CH - Svizzera 66
JO - Giordania 45
CA - Canada 43
BG - Bulgaria 40
AR - Argentina 39
BE - Belgio 37
NG - Nigeria 36
SC - Seychelles 33
ID - Indonesia 32
IR - Iran 26
LU - Lussemburgo 25
MX - Messico 25
AT - Austria 22
EC - Ecuador 20
HR - Croazia 16
PL - Polonia 16
GR - Grecia 14
CO - Colombia 13
ES - Italia 13
BD - Bangladesh 12
RO - Romania 11
TR - Turchia 11
CL - Cile 9
LT - Lituania 9
PH - Filippine 9
LB - Libano 8
PY - Paraguay 7
EG - Egitto 6
IQ - Iraq 6
UZ - Uzbekistan 6
AU - Australia 5
TW - Taiwan 5
AL - Albania 4
DK - Danimarca 4
PE - Perù 4
PK - Pakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KH - Cambogia 3
MA - Marocco 3
AO - Angola 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KG - Kirghizistan 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
UG - Uganda 2
VE - Venezuela 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
WS - Samoa 1
ZM - Zambia 1
Totale 17.680
Salva come PNG Salva come JPEG
Città #
Singapore 1.128
Southend 1.042
Ashburn 769
Fairfield 764
Chandler 476
Hong Kong 410
Dong Ket 394
Hefei 340
Houston 335
Woodbridge 334
Seattle 330
Wilmington 327
Cambridge 284
Ann Arbor 273
Princeton 270
Beijing 223
Santa Clara 197
Dublin 189
Jacksonville 179
Boardman 163
Seoul 132
Nanjing 120
Abidjan 110
Ho Chi Minh City 109
Westminster 106
Los Angeles 99
New York 95
Hanoi 94
Bologna 92
Lomé 92
Padova 89
Bremen 78
Tokyo 78
Berlin 77
Jinan 61
Milan 61
Dallas 60
Helsinki 58
Bern 56
Buffalo 56
London 54
Saint Petersburg 51
Shenyang 46
Amman 45
Hebei 44
Mülheim 44
San Diego 44
Nanchang 42
Munich 40
Redondo Beach 40
Sofia 40
Brussels 37
Changsha 37
Abeokuta 35
Tianjin 34
Bengaluru 31
Chicago 31
Frankfurt am Main 30
Guangzhou 28
Hyderabad 28
São Paulo 28
Medford 26
Redwood City 26
Zhengzhou 26
Turin 25
Redmond 24
Rome 24
Shanghai 24
Hangzhou 23
Jiaxing 22
San Venanzo 20
Toronto 20
Des Moines 19
Falkenstein 19
Olalla 19
Phoenix 19
Taizhou 19
Yubileyny 19
Haikou 18
Norwalk 18
Haiphong 17
Lappeenranta 17
Dearborn 16
Mahé 16
Dudelange 14
Jakarta 14
Florence 13
Fuzhou 13
Ningbo 13
Orem 13
Biên Hòa 12
Chennai 12
Falls Church 12
Taiyuan 12
Amsterdam 11
Brooklyn 11
Leawood 11
Nuremberg 11
Quận Bình Thạnh 11
Warsaw 11
Totale 11.629
Salva come PNG Salva come JPEG
Nome #
Biology and treatment of follicular lymphoma. 264
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens 254
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 248
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 247
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 231
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 226
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 221
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 207
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 206
Comparison of JAK2V617F-positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology 203
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 197
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 187
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 187
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 185
Histopathology of B-cell chronic lymphocytic leukemia. 174
A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy. 174
CD30 expression in peripheral T-cell lymphomas 172
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 172
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 170
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 170
Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience 169
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 169
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 168
CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation. 168
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 168
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 166
Anaplastic Large Cell Lymphoma: a critical reappraisal 165
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 165
BCL10 down-regulation in peripheral T-cell lymphomas. 160
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 159
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 159
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 159
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 157
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 157
Pathobiology of hodgkin lymphoma. 157
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 156
Small bowel obstruction caused by a large B-cell lymphoma in a patient with multicentric Castleman’s disease: an unusual occurrence 156
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 155
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 152
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 150
Pathobiology of anaplastic large cell lymphoma. 150
First Italian birth after cryopreserved ovarian tissue transplantation in a patient affected by non-Hodgkin's lymphoma 150
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. 148
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 147
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 147
Simple diagnostic assay for hairy cell leukemia by cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 146
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. 144
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis 144
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 144
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 144
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 143
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 141
Pathobiology of ALK-negative anaplastic large cell lymphoma. 141
Unusual inflammatory and hyperkeratotic halo naevus in children. 141
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. 140
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 140
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 139
Prognostic markers in peripheral T-cell lymphoma. 136
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 135
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 134
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease. 132
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 132
Brownish asymptomatic lesions on the arms and legs 132
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. 130
Granulomatous tattoo reaction in a nivolumab-treated patient 129
Primary cutaneous lymphomas: a reprisal 128
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 127
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 125
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 125
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 123
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in 5 cases. 122
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 122
Lymphoplasmacytic lymphoma and marginal zone lymphoma: diagnostic challenges 121
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 121
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 121
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 121
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 120
Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience 120
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma 119
Pathobiology of acute lymphoblastic leukemia. 118
SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients, methodological issue on reproducibility and validity—reply 118
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 116
Peripheral T-cell lymphoma. 114
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 114
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 113
Bone marrow in Hodgkin lymphoma and mimickers. 113
Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis. 112
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 112
Genetic and phenotypic attributes of splenic marginal zone lymphoma 111
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 111
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 111
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays. 110
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET 109
Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment 109
Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact 109
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 109
Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. 108
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 108
Lymphoma classification: Past, present and future 107
Marker expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score. 107
Totale 14.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.302 0 0 0 0 0 88 35 90 187 64 96 742
2021/20222.176 178 93 135 179 239 106 43 151 82 172 468 330
2022/20232.483 295 390 145 311 177 186 72 125 409 65 188 120
2023/2024713 37 120 62 56 64 159 45 52 23 52 13 30
2024/20252.918 136 447 283 209 391 142 243 96 44 197 161 569
2025/20263.672 624 675 622 612 809 330 0 0 0 0 0 0
Totale 18.038